Revised Geneva Score
Clinical prediction rule for estimating pre-test probability of pulmonary embolism
- Highest activation tier
- Recommended
- How it is scored
- Scored in code; a detected disagreeing draft value is flagged for correction
- Care settings
- Emergency department, Inpatient
When it activates
Scribeable activates a calculator from the encounter. The Revised Geneva Score can activate when the transcript or pasted chart context documents any of these:
- Suspected pulmonary embolism evaluation
- PE pre-test probability assessment
- PE workup decision
- Dyspnea with tachycardia evaluation
- Alternative to Wells PE criteria
A coded diagnosis can also activate it. ICD-10 prefixes carried by the registry: I26.
Note-type scope: it activates on notes whose subject resolves to emergency medicine, pulmonology, hospital medicine, cardiology. A note that resolves to another subject does not carry it even when the clinician's specialty matches; a note with no resolvable subject (a generic consultation) falls back to the specialty match.
Inputs the note needs
8 inputs. Each is resolved from the transcript, the pasted chart context and charted labs; at this calculator’s tier a missing input is never requested, and a missing required input keeps the score out of the draft.
| Input | Type | Unit / options | Guidance |
|---|---|---|---|
| Age >65 years | age | ||
| Previous DVT or PE | history | ||
| Surgery (under general anesthesia) or lower limb fracture within 1 month | history | ||
| Active malignant condition (solid or hematologic, currently active or <1 year) | history | ||
| Unilateral lower limb pain | symptom | ||
| Hemoptysis | symptom | ||
| Heart rate (for scoring: 75-94 or ≥95) | vital | bpm | |
| Pain on lower limb deep venous palpation and unilateral edema | exam |
Scoring
Age >65 (+1), Previous DVT/PE (+3), Surgery/fracture within 1 month (+2), Active malignancy (+2), Unilateral lower limb pain (+3), Hemoptysis (+2), Heart rate 75-94 (+3), Heart rate ≥95 (+5), Pain on deep palpation + unilateral edema (+4). Total range: 0-25.
Age>65 Age >65 years + 3×prior DVT/PE Previous DVT or PE + 2×recent surgery/fx Surgery (under general anesthesia) or lower limb fracture within 1 month + 2×active cancer Active malignant condition (solid or hematologic, currently active or <1 year) + 3×unilateral leg pain Unilateral lower limb pain + 2×hemoptysis Hemoptysis + HR Heart rate (for scoring: 75-94 or ≥95) (75-94=+3, ≥95=+5) + 4×deep palpation pain + edema Pain on lower limb deep venous palpation and unilateral edema
Interpretation
Score 0-3: Low probability (~8% PE prevalence) → D-dimer; if negative, PE excluded. Score 4-10: Intermediate probability (~28%) → D-dimer; if positive, CTPA. Score ≥11: High probability (~74%) → proceed directly to CTPA. Simplified version: each variable 0 or 1 point; ≤1 low, 2-4 intermediate, ≥5 high.
Evidence
Sources carried in Scribeable's citation registry for this calculator; guideline version: Le Gal G et al. 2006.
- Le Gal G et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva scoreLe Gal et al. (Revised Geneva) 2006 · 2006 · Level I · link last verified 2026-03-28
How Scribeable handles it in the note
When an encounter activates the Revised Geneva Score (its highest tier is recommended), Scribeable does not ask you for missing inputs. The score is computed in code from whatever inputs resolve from the transcript, the pasted chart context or charted labs; a computed value is written into the draft only when every required input already resolves.
The score is computed in code from the resolved inputs, not recalled by the language model. If the draft states a Revised Geneva Score value that disagrees with the computed one, the disagreement is flagged to the second drafting pass, which is instructed to correct the score and its interpretation before you see the note.
Classified as a mandatory rule-out score: a missed result carries acute harm, so the activation filter never approves it on uncertainty.
See it activate on your own encounter
14 days of full Pro. No sales call.
14-day Pro trial with a card on file. $79/month starts 14 days after your trial begins unless you cancel first. Cancel any time from Settings > Billing.